文献速递生殖医学

医学辅助生殖对意大利总生育率、年龄别生育率及胎次别生育率的贡献

The contribution of medically assisted reproduction to total, age-, and parity-specific fertility in Italy.
PubMed 文献 · Hum Reprod · 2025-01-01

该研究基于意大利2022年行政数据(分娩证书登记N=393 997、活产登记N=393 333、育龄女性人口N=17 006 665),估算医学辅助生殖(MAR)对总生育率、年龄别及胎次别生育率的贡献,并与2013年比较。结果显示2022年MAR对总生育率贡献3.7%(2013年2.1%),对一胎生育率贡献5.9%,40岁及以上女性中达16.2%,40-59岁女性一胎贡献达30.9%。

要点

  • 2022年MAR对意大利总生育率(15-59岁女性)贡献3.7%,较2013年2.1%上升。
  • 40岁及以上女性中MAR对总生育率贡献2022年达16.2%,2013年为8.6%。
  • MAR受孕女性首次分娩平均年龄2022年为37.8岁,自然受孕者为31.3岁。

核心结论

  • 2022年MAR对意大利总生育率贡献3.7%,对一胎生育率贡献5.9%,在40岁及以上女性中贡献显著更高。
  • MAR受孕女性的首次分娩平均年龄(37.8岁)远高于自然受孕女性(31.3岁),且较2013年(36.0岁)进一步推迟。

研究设计与样本

  • 基于意大利2022年全人群活产分娩的行政数据:分娩证书登记N=393 997、活产登记N=393 333、育龄女性人口N=17 006 665,并与2013年比较。
  • 计算MAR受孕与自然受孕的年龄别生育率(总数及胎次别),评估MAR对总生育率、胎次别生育率及平均生育年龄的贡献。

主要发现

  • MAR对总生育率(15-59岁女性)的贡献从2013年2.1%升至2022年3.7%。
  • 40岁及以上女性中,MAR对总生育率的贡献从2013年8.6%升至2022年16.2%。
  • 2022年MAR对一胎生育率的贡献为5.9%,在40-59岁女性中达30.9%。
  • MAR受孕女性首次分娩平均年龄2022年为37.8岁(2013年36.0岁),自然受孕女性2022年为31.3岁(2013年30.4岁)。

关键数值与推荐

  • MAR对总生育率贡献:2022年3.7% vs 2013年2.1%。
  • 40岁及以上女性中MAR对总生育率贡献:2022年16.2% vs 2013年8.6%。
  • 2022年MAR对一胎生育率贡献5.9%,40-59岁女性中达30.9%。
  • MAR受孕女性首次分娩平均年龄:2022年37.8岁 vs 2013年36.0岁;自然受孕女性:2022年31.3岁 vs 2013年30.4岁。

临床怎么用

  • 原文未据此给出临床推荐。
  • 作者指出意大利2025年1月生效的新法律将不孕症认定为疾病并大幅降低治疗费用,可能增加MAR需求,但需求能否转化为治疗可及性取决于卫生系统资源是否扩充。

局限性

  • 由于社会规范对非传统生育路径的抵触,意大利母亲可能比其他国家对MAR出生漏报更多,本方法可能低估MAR对总生育率的贡献。
  • 因官方统计无按年龄和胎次分层的女性人口,生育率计算使用基于全部育龄女性的无约束分母,未考虑胎次。
  • 估计值在一定程度上受接受MAR治疗的夫妇最终可能自然受孕的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the contribution of medically assisted reproduction (MAR) to total, age-, and parity-specific fertility in Italy? SUMMARY ANSWER: MAR contributed 3.7% to Italy's total fertility rate in 2022 and 5.9% to fertility of first order; MAR's contribution to fertility reached 16% among women aged 40 + and 31% among women aged 40 + at first birth. WHAT IS KNOWN ALREADY: Demography, particularly via postponement of the age at childbearing for both women and men, plays a role in the diffusion of MAR techniques, and the diffusion of MAR techniques may contribute to postpone the age at childbearing. Recent studies found that the contribution of MAR to fertility rates is remarkable and increases over time in countries such as Czech Republic, Denmark, Australia, and the USA. Italy is a country distinguished by one of the lowest average number of children per woman globally, as well as the highest maternal age at first birth and among the highest shares of births to mothers aged 40 years and over in Europe. No prior study has focused on Italy. STUDY DESIGN, SIZE, DURATION: This study relies on a unique combination of administrative data sources: the Certificate of Delivery Care Registry dataset based on the entire population of live birth deliveries in Italy in 2022 (N = 393 997), administered by the Ministry of Health; the Register of Live Births to the Resident Population in 2022 (N = 393 333), administered by the Italian National Institute of Statistics; and the resident population by age and sex to identify the female population at risk of having a(n additional) child by age (N = 17 006 665) provided by the Italian National Institute of Statistics. Comparisons are made with the year 2013. PARTICIPANTS/MATERIALS, SETTING, METHODS: We calculate the age-specific fertility rates (total and by parity) for births conceived via MAR and those conceived naturally. These rates are then utilized to assess the contribution of MAR to total and parity-specific fertility, as well as to the mean maternal age at childbearing. This study is the first estimation of its kind for Italy. MAIN RESULTS AND THE ROLE OF CHANCE: The contribution of MAR to the total fertility rate (for women aged 15-59 years) in Italy increased from 2.1% in 2013 to 3.7% in 2022. Among women aged 40 + , the contribution of MAR to the total fertility rate increases to 16.2% in 2022, up from 8.6% in 2013. The contribution of MAR to first-order fertility rate increases to 5.9% and it reaches 30.9% among women aged 40-59 years in 2022. The mean age at first childbirth among women who conceived via MAR equals to 37.8, up from 36.0 in 2013, compared to those who conceived naturally at a mean age at first birth of 30.4 in 2013 and of 31.3 in 2022. LIMITATIONS, REASONS FOR CAUTION: Our approach may underestimate MAR's contribution to the total fertility rate in Italy: mothers in Italy may be more likely to under-report of MAR-births than in other countries, due to social norms that are more resistant to non-conventional paths to parenthood. Our estimates use unconstrained denominators based on the entire population of women in reproductive age, irrespective of parity, to compute fertility rates because the population of women by age and parity is not available from official statistics. In addition, our estimates are somewhat affected by the possibility that couples who underwent MAR treatment would have eventually conceived spontaneously. WIDER IMPLICATIONS OF THE FINDINGS: Countries characterized by low and late fertility offer a unique test ground for studying the contribution of MAR to fertility rates. In Italy, a late transition to parenthood among the general population aligns with the late transition to parenthood among mothers who conceived via MAR, mirroring that they seek infertility treatments at a relatively late age. For Italy, it will be important to monitor MAR's contribution to fertility as a new law came into effect in January 2025, that, by recognizing infertility as a pathology, considerably reduces treatment costs hence likely increases demand for MAR. The extent to which a potentially increased demand will translate into access to treatment is uncertain if additional resources are not made available to expand the health system to meet the expected increased demand. STUDY FUNDING/COMPETING INTEREST(S): We acknowledge funding from Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8-Project Age-It: 'Ageing Well in an Ageing Society' (DM 1557 11.10.2022) and the project 'ALFA-Aligning Law with Family Arrangements' funded by Fondazione Cariplo 2021-1321. Open access funding provided by University of Trento within the CRUI-CARE agreement. The views and opinions expressed are only those of the authors and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them. No conflict of interest exists. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Burgio A, Castagnaro C, Vignoli D, et al. The contribution of medically assisted reproduction to total, age-, and parity-specific fertility in Italy. Hum Reprod. 2025. PMID: 40639806. doi:10.1093/humrep/deaf137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。